NewAmsterdam Pharma Co (NAMSW:NASDAQ)
$18.6 -1.45 (-7.23%)
Analysed NewAmsterdam Pharma Co (NAMSW:NASDAQ) News Sources
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Markets Insider
Analysts Offer Insights on Healthcare Companies: Arcellx Inc (ACLX) and Apellis Pharmaceuticals (APLS)
The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Rhythm Pharmaceuticals (RYTM), BeOne Medicines (ONC)
The Globe and Mail
Aurobindo Subsidiary Eugia Launches Generic Pomalyst Capsules in US
Medical Dialogues
Natco Pharma shares rise 2% on Pomalidomide capsules launch in US
Moneycontrol
Natco Pharma shares rise 3% in weak mkt on launching generic Pomalyst in US
Business Standard
Natco Pharma gains on Pomalidomide capsules launch in US
Business Standard
NATCO Pharma launches generic blood cancer treatment medicine in US
The Economic Times on MSN
Indian Pharma’s 'Sema' Storm: Over 50 Semaglutide Brands Queue Up As Ozempic Patent Expires
News18
3 AI tools that actually work
Medical Marketing & Media
What is the current price of NewAmsterdam Pharma Co (NAMSW:NASDAQ)?
The current price of NewAmsterdam Pharma Co (NAMSW:NASDAQ) is $18.6.
NewAmsterdam Pharma Co (NAMSW:NASDAQ) absolute price change since previous trading day?
The absolute price change of NewAmsterdam Pharma Co (NAMSW:NASDAQ) since the previous trading day is $-1.45.
NewAmsterdam Pharma Co (NAMSW:NASDAQ) percentage price change since previous trading day?
The percentage price change of NewAmsterdam Pharma Co (NAMSW:NASDAQ) since the previous trading day is -7.23%.
What is This Week's average sentiment score for NewAmsterdam Pharma Co (NAMSW:NASDAQ)?
This Week's average sentiment score for NewAmsterdam Pharma Co (NAMSW:NASDAQ) is 79 out of 100.
What is This Week's average sentiment for NewAmsterdam Pharma Co (NAMSW:NASDAQ)?
This Week's sentiment for NewAmsterdam Pharma Co (NAMSW:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.